-
We might need to redefine our approach to drug discovery and approval to be prepared for the future
expresspharma
January 08, 2021
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his organisation’s plans for future growth and more, in an interview with Lakshmpriya Nair.
-
Commerce Secretary reaffirms India’s commitment to ensuring equitable and affordable access to vaccines and COVID-treatments for all
expresspharma
January 08, 2021
As India’s 7th Trade Policy Review at the WTO begins, members applauded India’s leadership role in the global efforts against the COVID-19 pandemic, acknowledging India’s position as the ‘pharmacy of the world’.
-
Trial to evaluate monoclonal antibody therapy for mild-to-moderate COVID-19
europeanpharmaceuticalreview
January 07, 2021
The study will determine if the combination of BRII-196 and BRII-198, two investigational antibodies for SARS-CoV-2, can prevent disease progression.
-
Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
prnewswire
January 07, 2021
Windtree Therapeutics, Inc. announced that it has dosed the first patient in its Phase 2 clinical trial studying lucinactant in acute lung injury in adults with COVID-19 associated lung injury and acute respiratory distress syndrome (ARDS).
-
OSE Immunotherapeutics Receives Funding for Second Generation COVID-19 Vaccine
americanpharmaceuticalreview
January 07, 2021
OSE Immunotherapeutics announces the Company has obtained funding of €5.2 million under the PSPC-COVID call for projects, operated on behalf of the French government by Bpifrance as part of the Programme d’investissements d’avenir (PIA) and led by the ...
-
Emergex Signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz
contractpharma
January 07, 2021
Agreement provides a framework for future clinical trials, manufacturing, sales and marketing, and distribution within the National Health Service of Brazil.
-
COVID-19 vaccine key conversation driver for Pfizer among Twitter influencers during Q4 2020– GlobalData
expresspharma
January 07, 2021
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK and the US Food and Drug Administration (FDA) authorised Pfizer and BioNTech’s mRNA vaccine (BNT162b2) for emergency use against COVID-19 in December 2020.
-
Include pharma workforce in priority list for COVID-19 vaccination: Pharma associations
expresspharma
January 07, 2021
The proposed move will benefit over two million workforce and ensure uninterrupted supply of medicines in the country, say associations.
-
Novel COVID-19 test could significantly reduce testing time
europeanpharmaceuticalreview
January 06, 2021
The new COVID-19 test, called RTF-EXPAR, was able to accurately detect the presence of SARS-CoV-2 viral RNA in under five minutes.
-
Akston Biosciences and LakePharma Enter Covid-19 Partnership
contractpharma
January 06, 2021
?Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a U.S.-based CRDMO serving the biotechnology community with development and production services, have established a strategic partnership.